MetLife MET
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 65th percentile, 5-year average 17.0x
#1513 of 2972 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 97th percentile, 5-year average 1.7x
#3272 of 5311 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 88th percentile, 5-year average 0.7x
#1401 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.32 | – | 1.69 | 97% (pricier than usual) | #3272 of 5311 (1 = cheapest) |
| PE | 19.16 | 9.89 | 17.02 | 65% (pricier than usual) | #1513 of 2972 (1 = cheapest) |
| PS | 0.80 | 0.78 | 0.73 | 88% (pricier than usual) | #1401 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on MET.
Sign in to join the discussion.